Johnson & Johnson announced today that its worldwide sales in 2018 totaled $81.6 billion—a 6.7% increase from 2017—with adjusted diluted earnings per share of $8.18.
Top takeaways from the newly released annual earnings report include:
- Worldwide Consumer sales were $13.9 billion
- Worldwide Medical Devices sales totaled $27 billion
- Worldwide Pharmaceutical sales added up to $40.7 billion
Most notably, the company's Pharmaceutical sales were up 12.4%.
This infographic provides more details about Johnson & Johnson’s full year results, along with a message from, the company’s Chairman and Chief Executive Officer.